Stem Cell Global Symposium : Stem Cell Company

Diseases Details

Myelodysplastic Syndromes [View testimonials]
Myelodysplastic syndromes are bone marrow stem cell disorders resulting in disorderly and ineffective hematopoiesis (blood production) manifested by irreversible quantitative and qualitative defects in hematopoietic (blood-forming) cells. In a majority of cases, the course of disease is chronic with gradually worsening cytopenias due to progressive bone marrow failure. Approximately one-third of patients with MDS progress to AML within months to a few years.

Symptoms:

Anemia—chronic tiredness, shortness of breath, chilled sensation, sometimes chest pain
Neutropenia (low neutrophil count) —increased susceptibility to infection
Thrombocytopenia (low platelet count) —increased susceptibility to bleeding and ecchymosis (bruising), as well as subcutaneous hemorrhaging resulting in purpura or petechia
neutropenia, anemia and thrombocytopenia (low cell counts of white and red blood cells, and platelets, respectively);
splenomegaly or rarely hepatomegaly;
abnormal granules in cells, abnormal nuclear shape and size; and/or
chromosomal abnormalities, including chromosomal translocations and abnormal chromosome number.

Stem Cell Therapy:
Now, such incurable diseases can be treated by Stem Cell Therapy.

Where Stem cells are being taken from patient’s own bone marrow, Adipose derived fat stem cells, peripheral blood derived stem cells or Umbilical cord blood-derived & placenta-derived immune rejection free stem cells. No. of experts in different parts of the world say Germany, Mexico, Ukraine, India, China and many more have treated thousands of patients suffering from incurable disease improving their Life quality.

To get your medical condition evaluated by this global medical experts team & to contact experienced patients in this regard, contact SCGF or become its member.

Get in touch
Name
Email
Contact No.
Inquiry/query